Friedberg Ezra M 4
4 · Pelthos Therapeutics Inc. · Filed May 18, 2026
Research Summary
AI-generated summary of this filing
Pelthos (PTHS) Director Ezra Friedberg Sells 144 Shares
What Happened
- Ezra M. Friedberg, a director of Pelthos Therapeutics (PTHS), disposed of 144 shares on May 14, 2026 to satisfy estimated tax obligations tied to the vesting of restricted stock units. The weighted-average sale price was $27.01 per share, for total proceeds of approximately $3,889. This was a sale (tax-withholding) rather than an open-market purchase.
Key Details
- Transaction date: 2026-05-14; Form 4 filed: 2026-05-18 (filed late — transactionTimeliness = L).
- Price: weighted average $27.01; executed in multiple trades at $27.00 to $27.0101.
- Shares reported disposed: 144; aggregate value ≈ $3,889.
- Shares owned after transaction: not disclosed in the provided filing.
- Notable footnotes:
- Sale made pursuant to a Rule 10b5-1 plan adopted Dec 16, 2025 to satisfy tax obligations from RSU vesting (Footnote F1).
- Reporting person will provide detailed trade-by-trade info on request (Footnote F2).
- Mr. Friedberg is manager of Balmoral Financial Group LLC and Key Recovery Group LLC and may be deemed to beneficially own shares held by those entities, though he disclaims such ownership except to the extent of any pecuniary interest (Footnote F3).
Context
- Transaction code F indicates shares were used for tax withholding related to vesting (common administrative transaction), not a directional investment bet. The sale was executed under a prearranged 10b5-1 plan, which reduces timing-question concerns. The late filing (4 days after the trade) is noted by the filer and may be an administrative tardiness rather than substantive trading activity.
Insider Transaction Report
Form 4
Friedberg Ezra M
Director
Transactions
- Tax Payment
Common Stock
[F1][F2]2026-05-14$27.01/sh−144$3,889→ 81,883 total
Holdings
- 82,072(indirect: By LLC)
Common Stock
[F3] - 40,000(indirect: By LLC)
Common Stock
[F3]
Footnotes (3)
- [F1]This transaction reflects the sale of shares, made pursuant to a Rule 10b5-1 plan adopted December 16, 2025, for the purpose of satisfying estimated tax obligations in connection with the vesting of restricted stock units granted by the Issuer.
- [F2]This transaction was executed in multiple trades at prices ranging from $27.00 to $27.0101. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock sold. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]Ezra Friedberg is the manager of Balmoral Financial Group LLC ("Balmoral") and the manager of Key Recovery Group LLC ("Key"). By virtue of this relationship, Mr. Friedberg may be deemed to beneficially own the shares of Common Stock held of record by each of Balmoral and Key. Mr. Friedberg disclaims any such beneficial ownership except to the extent of his pecuniary interest therein.
Signature
/s/ John M. Gay, by power of attorney|2026-05-18